down arrow

Aspira Pathlab

  • Market Cap: Micro Cap
  • Industry: Hospital & Healthcare Services
  • ISIN: INE500C01017
  • NSEID:
  • BSEID: 540788
INR
68.00
2.06 (3.12%)
BSENSE

Apr 11, 12:49 PM

BSE+NSE Vol: 1715

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

63.0069.23

52 Week

25.00106.78
Valuation
Technical
Day's Volume

CASH

1.72 k (-14.75%) Volume

Shareholding (Dec 2024)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

18.55%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Weak Long Term Fundamental Strength with a 16.95% CAGR growth in Operating Profits over the last 5 years

  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.80
  • The company has been able to generate a Return on Capital Employed (avg) of 9.26% signifying low profitability per unit of total capital (equity and debt)
2

The company has declared Positive results for the last 3 consecutive quarters

3

Stock is technically in a Mildly Bullish range

4

With ROE of 7.7, it has a Attractive valuation with a 6.1 Price to Book Value

5

Majority shareholders : Non Institution

 
6

Market Beating Performance

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Hospital & Healthcare Services

stock-summary
Market cap

INR 68 Cr (Micro Cap)

stock-summary
P/E

68.00

stock-summary
Industry P/E

55

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.01

stock-summary
Return on Equity

7.65%

stock-summary
Price to Book

6.11

Revenue and Profits (1 Year):
Net Sales:
5 Cr
(Quarterly Results - Dec 2024)
Net Profit:
0 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
49.61%
0%
49.61%
1 Year
110.72%
0%
110.72%
2 Years
104.2%
0%
104.2%
3 Years
-1.45%
0%
-1.45%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Aspira Pathlab for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
26.38%
EBIT Growth (5y)
16.95%
EBIT to Interest (avg)
0.80
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.75
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
-17.97%
ROE (avg)
14.16%
Valuation key factors
Factor
Value
P/E Ratio
68
Industry P/E
55
Price to Book Value
6.11
EV to EBIT
67.94
EV to EBITDA
28.55
EV to Capital Employed
6.08
EV to Sales
3.39
PEG Ratio
0.50
Dividend Yield
NA
ROCE (Latest)
-2.42%
ROE (Latest)
7.65%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Deepali Arvind Bhanushali (8.6%)

Highest Public shareholder

Rinku Vinod Bhanushali (8.1%)

Individual Investors Holdings

60.28%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 56.36% vs -20.82% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 151.35% vs -268.18% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5.41",
          "val2": "3.46",
          "chgp": "56.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.77",
          "val2": "-0.38",
          "chgp": "302.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.09",
          "val2": "0.09",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.38",
          "val2": "-0.74",
          "chgp": "151.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "14.23%",
          "val2": "-10.98%",
          "chgp": "25.21%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 82.29% vs -11.23% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 167.83% vs -429.63% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "10.81",
          "val2": "5.93",
          "chgp": "82.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.70",
          "val2": "-0.69",
          "chgp": "346.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.16",
          "val2": "0.19",
          "chgp": "-15.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.97",
          "val2": "-1.43",
          "chgp": "167.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "15.73%",
          "val2": "-11.64%",
          "chgp": "27.37%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 72.74% vs -15.02% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 162.21% vs -1,376.47% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "16.22",
          "val2": "9.39",
          "chgp": "72.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2.47",
          "val2": "-1.07",
          "chgp": "330.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.25",
          "val2": "0.28",
          "chgp": "-10.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1.35",
          "val2": "-2.17",
          "chgp": "162.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "15.23%",
          "val2": "-11.40%",
          "chgp": "26.63%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is -8.71% vs -26.00% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -2,866.67% vs -102.02% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "13.20",
          "val2": "14.46",
          "chgp": "-8.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.19",
          "val2": "1.60",
          "chgp": "-174.38%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.37",
          "val2": "0.42",
          "chgp": "-11.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-2.67",
          "val2": "-0.09",
          "chgp": "-2,866.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-9.02%",
          "val2": "11.07%",
          "chgp": "-20.09%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
5.41
3.46
56.36%
Operating Profit (PBDIT) excl Other Income
0.77
-0.38
302.63%
Interest
0.09
0.09
Exceptional Items
0.00
0.00
Standalone Net Profit
0.38
-0.74
151.35%
Operating Profit Margin (Excl OI)
14.23%
-10.98%
25.21%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is 56.36% vs -20.82% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in quarter ended Dec 2024 is 151.35% vs -268.18% in Dec 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
10.81
5.93
82.29%
Operating Profit (PBDIT) excl Other Income
1.70
-0.69
346.38%
Interest
0.16
0.19
-15.79%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.97
-1.43
167.83%
Operating Profit Margin (Excl OI)
15.73%
-11.64%
27.37%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 82.29% vs -11.23% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is 167.83% vs -429.63% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
16.22
9.39
72.74%
Operating Profit (PBDIT) excl Other Income
2.47
-1.07
330.84%
Interest
0.25
0.28
-10.71%
Exceptional Items
0.00
0.00
Standalone Net Profit
1.35
-2.17
162.21%
Operating Profit Margin (Excl OI)
15.23%
-11.40%
26.63%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 72.74% vs -15.02% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is 162.21% vs -1,376.47% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
13.20
14.46
-8.71%
Operating Profit (PBDIT) excl Other Income
-1.19
1.60
-174.38%
Interest
0.37
0.42
-11.90%
Exceptional Items
0.00
0.00
Standalone Net Profit
-2.67
-0.09
-2,866.67%
Operating Profit Margin (Excl OI)
-9.02%
11.07%
-20.09%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is -8.71% vs -26.00% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is -2,866.67% vs -102.02% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Aspira Pathlab & Diagnostics Ltd stock-summary
stock-summary
Aspira Pathlab & Diagnostics Ltd
Micro Cap
Hospital & Healthcare Services
Aspira Pathlab & Diagnostics Limited (ASDL) was incorporated in July, 1973. ASDL is a leading pathology specialist, with Pan-India presence. It offer pathology and diagnostic services to individual patients, hospitals, other healthcare providers, and businesses. The Company, with a wider presence in Maharashtra India, enjoys a loyal customer base, that reflects on its strength as a brand, providing superior diagnostic testing and services.
Company Coordinates stock-summary
Company Details
Flat No. 2 RD Shah Building, Shraddanand Road Ghatkopar(W) Mumbai Maharashtra : 400086
stock-summary
Tel: 91-22-71975756/5656
stock-summary
http://www.aspiradiagnostics.com
stock-summary
info@aspiradiagnostics.com/urkalsoa
Registrar Details
Sharex Dynamic (India) Pvt Ltd , Unit -1, Luthra Ind. Premises , Safed Pool, Andheri-Kurla Road, Andheri (E), Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."